WASHINGTON — Whether they want to or not, consumers will soon know how many calories they are eating when ordering off the menu at chain restaurants, picking up prepared foods at supermarkets and even eating a tub of popcorn at…
By Lauran Neergaard, Associated Press
Self-injury is one of the most difficult behaviors associated with autism and other developmental or intellectual disabilities, and a private facility outside Boston that takes on some of the hardest-to-treat cases is embroiled in a major debate: Should it use…
By Anna Christiansen
Starting this week, all food products marked as “gluten-free” can only make the claim if they contain less than 20 parts per million of gluten.
Americans are a small step closer to accessing less-expensive specialty drugs known as biologics. The Food and Drug Administration for the first time accepted an application for the approval of a copycat “generic” version of the brand name drug Neupogen,…
By Megan Thompson
A new study claims pharmaceutical companies may be misusing FDA safety guidelines to block generic drugs from market, costing the health care system more than $5 billion dollars a year.
By Joshua Barajas
Although lawmakers have repeatedly called on Congress to create a special office within the FDA to regulate health apps available in the mobile marketplace, the idea was rejected at a roundtable discussion on medical device security in…
By Victoria Pasquantonio
As of January of this year, there were more than 460 e-cigarette brands available for purchase online, and around 7,700 flavors, including Swedish fish, roasted marshmallow and vanilla cupcake.
By Stephen Fee
This May, Colorado's governor signed the nation's first "right to try" bill, which allows terminally ill patients to try unapproved — and potentially dangerous — drugs outside of clinical trials and without approval from federal regulators.
By Mike Sherry, The Hale Center for Journalism
If you were dying and had exhausted all conventional treatment options, wouldn’t you want immediate access to a drug that might prove to be a miracle cure? That’s the promise of proposed legislation that could make Missouri the third state…
Terminally ill patients often are frustrated to hear about experimental drugs they think might help them, but have not yet been approved by the Food and Drug Administration -- a process that often takes years.
Support Provided By: Learn more